Zhongzhi Pharmaceutical Holdings (HKSE:03737) YoY EBITDA Growth : 7.26% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Zhongzhi Pharmaceutical Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Zhongzhi Pharmaceutical Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 7.26%.

Zhongzhi Pharmaceutical Holdings's EBITDA per Share for the six months ended in Dec. 2024 was HK$0.13.

Zhongzhi Pharmaceutical Holdings YoY EBITDA Growth Historical Data

The historical data trend for Zhongzhi Pharmaceutical Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhi Pharmaceutical Holdings YoY EBITDA Growth Chart

Zhongzhi Pharmaceutical Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

30.54

-42.16

36.89

33.12

-18.29

Zhongzhi Pharmaceutical Holdings Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															180.95	43.00	5.08	-28.67	7.26

Zhongzhi Pharmaceutical Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Zhongzhi Pharmaceutical Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(0.335	-	0.41)	/	\| 0.41 \|
=	-18.29 %

Zhongzhi Pharmaceutical Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(0.133	-	0.124)	/	\| 0.124 \|
=	7.26 %

Zhongzhi Pharmaceutical Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Zhongzhi Pharmaceutical Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongzhi Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN

Website

https://www.zeus.cn

Zhongzhi Pharmaceutical Holdings Ltd is engaged in the business of manufacturing and selling pharmaceutical products. The group's operations are divided into two segments, namely Pharmaceutical manufacturing, and Operation of chain pharmacies. In the Pharmaceutical manufacturing segment, the company is engaged in the research and development, manufacturing, and sale of Chinese patent medicines. In the Operation of chain pharmacies segment, the firm operates chain pharmacies in Zhongshan under the brand Zeus for the sale of pharmaceutical products. It derives a majority of its revenue from the PRC.

Executives

Jiang Li Xia	2202 Interest of your spouse
Lai Zhi Tian	2201 Interest of corporation controlled by you
Crystal Talent Investment Group Limited	2101 Beneficial owner
Cheng Jin Le	2201 Interest of corporation controlled by you
Advance Keypath Global Investment Limited	2101 Beneficial owner
Novich Positioning Investment (cayman) Limited	2201 Interest of corporation controlled by you
Novich Positioning Investment Limited Partnership	2101 Beneficial owner

Zhongzhi Pharmaceutical Holdings Headlines

No Headlines